Cargando…
Three perspectives on the molecular basis of hypercontractility caused by hypertrophic cardiomyopathy mutations
Several lines of evidence suggest that the primary effect of hypertrophic cardiomyopathy mutations in human β-cardiac myosin is hypercontractility of the heart, which leads to subsequent hypertrophy, fibrosis, and myofilament disarray. Here, I describe three perspectives on the molecular basis of th...
Autor principal: | Spudich, James A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6475635/ https://www.ncbi.nlm.nih.gov/pubmed/30767072 http://dx.doi.org/10.1007/s00424-019-02259-2 |
Ejemplares similares
-
Hypertrophic cardiomyopathy β-cardiac myosin mutation (P710R) leads to hypercontractility by disrupting super relaxed state
por: Vander Roest, Alison Schroer, et al.
Publicado: (2021) -
Hypertrophic cardiomyopathy: Mutations to mechanisms to therapies
por: Kawana, Masataka, et al.
Publicado: (2022) -
Biophysical properties of human β-cardiac myosin with converter mutations that cause hypertrophic cardiomyopathy
por: Kawana, Masataka, et al.
Publicado: (2017) -
Altered force generation and cell-to-cell contractile imbalance in hypertrophic cardiomyopathy
por: Kraft, Theresia, et al.
Publicado: (2019) -
Airway Smooth Muscle Hypercontractility in Asthma
por: Berair, Rachid, et al.
Publicado: (2013)